Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase I/II trial to study the effectiveness of temozolomide and vinorelbine in
treating patients who have recurrent brain metastases.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborators:
National Cancer Institute (NCI) Northwestern Memorial Hospital